Enhanced Metal Reduction Techniques for Definitive CT Scanning to Assess Spinal Fusion With TM-Ardis
- Conditions
- Degenerative Disc Disease
- Interventions
- Device: TM- Ardis implant and Metal Reduction CT software
- Registration Number
- NCT02170558
- Lead Sponsor
- Zimmer Biomet
- Brief Summary
To determine if the subject metal reduction software helps to better visualize bone interphase and fusion reliability. Assess whether the appropriate procedural modification facilitates clearer images when implanted with a trabecular metal spinal implant
- Detailed Description
To determine if the subject metal reduction software helps to better visualize bone interphase and fusion reliability, and assess whether the appropriate procedural modification facilitates clearer images when implanted with a trabecular metal spinal implant.
Recruitment & Eligibility
- Status
- WITHDRAWN
- Sex
- All
- Target Recruitment
- Not specified
- A signed informed consent.
- Male or non-pregnant female scheduled for Trabecular Metal (TM - Ardis) implant, single level lumbar.
- Participant must be at least 18 years of age.
- Patient is pregnant Patient is unable to comprehend the requirements of the study.
- Patient is unable to undergo scanning (due to body habitus, inability to comply with positioning requirements, etc.).
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Patients implanted w/TM-Ardis TM- Ardis implant and Metal Reduction CT software Patients who are receiving a TM-Ardis implant for degenerative disc disease will have a CT scan immediate post op (2 weeks) and again at 6 months to determine if fusion can be assessed with the study metal reduction software. Will utilize TM- Ardis implant and Metal Reduction CT software
- Primary Outcome Measures
Name Time Method CT scan to determine if the study software can reduce metal scatter on the scan. 6 month post operative Each CT scan will be evaluated to asses if you can visualize fusion, bone interface, and/or device migration with an experimental metal reduction software for CT scan
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
St Alphonsus Regional Medical Center
🇺🇸Boise, Idaho, United States